PlainRecalls
FDA Drug Low Class III Terminated

Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution, Rx only, Distributed by: Genentech, Inc. NDC:50242-175-05

Reported: May 5, 2021 Initiated: April 20, 2021 #D-0357-2021

Product Description

Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution, Rx only, Distributed by: Genentech, Inc. NDC:50242-175-05

Reason for Recall

Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.

Details

Recalling Firm
Genentech Inc
Units Affected
2,627 bottles
Distribution
Distributed Nationwide in the USA.
Location
South San Francisco, CA

Frequently Asked Questions

What product was recalled?
Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution, Rx only, Distributed by: Genentech, Inc. NDC:50242-175-05. Recalled by Genentech Inc. Units affected: 2,627 bottles.
Why was this product recalled?
Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 5, 2021. Severity: Low. Recall number: D-0357-2021.